Specialised commissioning process 'lacks transparency', NHS England told


Charities, an MP and the pharmaceuticals industry have heavily criticised NHS England’s specialised commissioning process for “lacking transparency” about how it makes “life and death” funding decisions.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here